Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

about

Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Item

http://www.wikidata.org/entity/Q55427963

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Permanent prostate brachythera ...... tic resonance imaging markers.

@en

Permanent prostate brachythera ...... tic resonance imaging markers.

@nl

type

Item

label

Permanent prostate brachythera ...... tic resonance imaging markers.

@en

Permanent prostate brachythera ...... tic resonance imaging markers.

@nl

prefLabel

Permanent prostate brachythera ...... tic resonance imaging markers.

@en

Permanent prostate brachythera ...... tic resonance imaging markers.

@nl

P1476

Permanent prostate brachythera ...... tic resonance imaging markers.

@en

P2093

Geoffrey V Martin

http://www.w3.org/2001/XMLSchema#string

Jihong Wang

http://www.w3.org/2001/XMLSchema#string

Pierre Blanchard

http://www.w3.org/2001/XMLSchema#string

Rajat J Kudchadker

http://www.w3.org/2001/XMLSchema#string

Steven J Frank

http://www.w3.org/2001/XMLSchema#string

Teresa L Bruno

http://www.w3.org/2001/XMLSchema#string

Tharakeswara Bathala

http://www.w3.org/2001/XMLSchema#string

Thomas J Pugh

http://www.w3.org/2001/XMLSchema#string

Usama Mahmood

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience

Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.

Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.

MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy

A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.

Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility study.

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.

Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema.

MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer.

P304

761-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BRACHY.2017.04.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28501429

http://www.w3.org/2001/XMLSchema#string

P921

brachytherapy

P932

6003422

http://www.w3.org/2001/XMLSchema#string